Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway

NCT07629167 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT07629167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07629167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Not yet recruiting
Start date
August 30, 2026
Completion date
March 30, 2030
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acneiform drug eruption, acneiform eruptions